After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
G1 Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of G1 Therapeutics Inc is $208.80M. A total of 1.12 million shares were traded on the day, compared to an average of 1.46M shares.
In the most recent transaction, Umstead John W. V sold 6,547 shares of GTHX for 3.02 per share on Mar 18 ’24. After the transaction, the Chief Financial Officer now owns 123,896 company shares. In a previous transaction on Feb 12 ’24, Malik Rajesh sold 28,600 shares at 4.62 per share. GTHX shares that Chief Medical Officer owns now total 169,938.
Among the insiders who sold shares, MURDOCK TERRY L disposed of 721 shares on Jan 04 ’24 at a per-share price of $2.94. This resulted in the Chief Operating Officer holding 103,638 shares of GTHX after the transaction. In another insider transaction, Avagliano Mark sold 721 shares at $2.94 per share on Jan 04 ’24. Company shares held by the Chief Business Officer now total 117,834.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, GTHX has a high of $5.00 and a low of $1.08.
As of this writing, GTHX has an earnings estimate of -$0.21 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.22. The company reported an EPS of -$0.35 in the last quarter, which was -6.10% lower than expectations of -$0.33.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GTHX’s latest balance sheet shows that the firm has $221.19M in Cash & Short Term Investments as of fiscal 2021. There were $81.94M in debt and $27.61M in liabilities at the time. Its Book Value Per Share was $0.68, while its Total Shareholder’s Equity was $143.54M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GTHX is Buy with a score of 4.00.
